Inhibition Of Protein Tyrosine Phosphatase-1B In Vitro And In Vivo | 63543
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand
Google scholar citation report
Citations : 1536

Journal of Biotechnology & Biomaterials received 1536 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Inhibition of protein tyrosine phosphatase-1B in vitro and in vivo

Joint Event on 15th World Congress on Biotechnology And Biotech Industries Meet and 2nd International Conference on Enzymology and Molecular Biology

Marvin W Makinen

The University of Chicago, USA

Keynote: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.069

A large number of studies on protein tyrosine phosphatases (PTPases) have been directed towards drug design for therapeutic intervention because of their critical roles in homeostasis and disorders of metabolism. In contrast to protein tyrosine kinases, virtually all inhibitors tested against PTPases exhibit only competitive behavior because of their consensus, active site sequence H/V-C-X 5-R-S/T, a condition leading to low specificity. Having identified protein tyrosine phosphatase- 1B (PTP1B) as the target enzyme of the vanadyl (VO2+) chelate bis(acetylacetonato)oxidovanadium(IV) [VO(acac)2] in cultured 3T3-L1 adipocytes, we have investigated the basis of inhibition by the VO2+-chelate through steady-state, kinetic investigations of the recombinant human enzyme (residues 1-321). Our results differ from investigations by others because we compared the influence of the chelate in the presence of the synthetic substrate p-Nitrophenylphosphate (pNPP) and the phosphotyrosine-containing undecapeptide DADEpYLIPQQG mimicking residues 988-998 of the epidermal growth factor receptor, a physiologically relevant substrate. We also compared the inhibitory behavior of VO(acac)2 to that of two other VO2+-chelates similarly known for their capacity to enhance cellular uptake of glucose as insulin mimetics. The results indicate that VO (acac)2 acts as a classical uncompetitive inhibitor in the presence of DADEpYLIPQQG but exhibits only apparent competitive inhibition with pNPP as substrate because uncompetitive inhibitors are more potent pharmacologically than competitive inhibitors, structural characterization of the site of uncompetitive binding of VO(acac)2 to PTP1B may provide a new approach to design of inhibitors of high specificity for therapeutic purposes.

Marvin W. Makinen is Professor in the Department of Biochemistry and Molecular Biology in The University of Chicago, USA and has served as chairman of the department from 1988 to 1993. He is also a founding member of the Human Rights Board at the university. He did his D.Phil., in the year 1976 in Molecular Biophysics at Oxford University, U.K. Over the past 40 years at The University of Chicago, research in the Makinen lab has been directed towards the structural basis of action of metalloenzymes and the application of magnetic resonance methods to characterize active site structure and stereochemical relationships of substrates to active site residues in true reaction intermediates. More recent studies have been carried out to identify the target enzymes of metal -chelates that enhance the cellular uptake of glucose. Because some metal-chelates are associated with the capacity to enhance preferential uptake of glucose into xenograft tumors in small laboratory animal models, present research has been directed towards testing their potential as pharmacologic reagents to increase sensitivity of detection of malignant lesions by PET imaging.

Email: [email protected]